TAK-875 is a selective GPR40 agonist with EC50 of 14 nM, 400-fold more potent than oleic acid. Ch..
GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective aga..
GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase ..